Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and
Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today a
letter from Aurelio Useche, CEO to shareholders to clarify
misconceptions and rumours in the market about a compliance news
release disseminated on July 1, 2019 by the Company pursuant to a
request from the OTC Markets Group.
Dear shareholders,
The Management of Relevium or any publicly
traded company has the responsibility to dispel unfounded rumours,
misinformation or false statements which result in unusual market
activity. Misleading and manipulative promotion, positive or
negative, clearly fall into this area of concern and must be
immediately addressed.
As CEO, director and shareholder of Relevium
Technologies Inc. I feel it necessary to issue this letter and
issue a clear and direct clarification regarding inaccurate and
misleading statements being made by independent blog and referral
traffic investor website equity.guru and Mr. Chris Parry. On the
article published today, Mr. Parry misleads readers with false
allegations, which we feel should be of concern to all
investors.
Mr. Parry states that the Company is under
“promotional investigation” and provides a misleading opinion
stating, “reveals worst disclosure ever”. The fact is that Company
is not under any promotional investigation, but rather it was
contacted by OTC compliance on June 27th as it became aware of
promotional statements made by unrelated third parties with
potentially promotional content about Relevium Technologies. On its
website on Promotion Policy, the OTC markets states that although a
company whose security is being promoted may not be directly
involved or even aware of a promotion campaign for their
securities, all public companies have an obligation to provide
accurate disclosure to investors and quickly address any misleading
information that could affect the trading market for their
securities. This is why we, upon the request of the OTC, we issued
a news release in this regard.
Mr. Parry dangerously makes the insinuation that
the purchase of 4.3M shares by my holding company, which was a
private transaction conducted one month prior to the promotional
activity are somewhat related. This statement makes Mr. Parry
liable for defamation, libel and false light and I am taking this
matter very seriously, under the advice of my legal counsel. Mr.
Parry fails to disclose that I have never sold a single share, that
I have participated on all previous financings of the corporation
and that the purchase was made at a significant premium to market
(north of 60%) in full compliance and disclosure. Mr. Parry fails
to let the readers know that I have a spotless 27-year-old career
with an extensive educational and professional background,
including 21 untarnished years in the public markets.
Finally, Mr. Parry provides a misleading
connection between the disclosure statements provided by the
promotional news outlet and the Company. The fact is, that as
disclosed in full compliance with OTC requirements, the Company
confirms it was not involved nor recognizes the source of the said
promotional newsletter. Regardless of whether Mr. Parry agrees or
not with the disclosure statements of the third party, it is a
statement used by many US based investor awareness companies. Our
Company engages, from time-to-time, third party providers for
investor awareness, all of which are standard in the capital
markets. In full compliance with the OTC request, our Company
provided a detailed list of the companies we have worked with in
the last twelve months.
We at Relevium BELIEVE and are fully engaged in
the success of our Company. We believe that the market has yet to
fully recognize the value of our Company, but we also know that it
is the execution of our strategy and not promotion that will
eventually bring about the correct market recognition of the value
of RLV. However, we also believe that recognition requires we reach
a wider audience and we are committed to a fully transparent and
compliant disclosure of our activities over the years to come.
Our company benefits from a very loyal and
longstanding shareholder base and we will continue to focus on our
mission and on building a leading and responsible corporation in
the health and wellness market.
We thank you for the trust you have placed on
us.
Yours respectfully,
Aurelio Useche, CEO
About Relevium Technologies
Relevium is a publicly-traded company that
operates in the health and wellness industry, including legal
cannabis, with a primary focus on online distribution. The
principal business of the Company is the identification,
evaluation, acquisition and operation of brands and businesses in
the health and wellness markets and medical cannabis. The Company
pursues its business strategy through an acquisition and
partnership model in a holistic approach to encompass a wide range
of health and wellness consumer products. Relevium operates through
two wholly owned subsidiaries:
BGX E-Health LLC (BGX), based in Orlando,
Florida, markets dietary supplements, nutraceuticals, sports
nutrition and cosmeceuticals primarily through its Bioganix® brand
portfolio in the US and Europe. Relevium’s premium brands are sold
at some of the world’s largest retailers including Walmart.com and
Amazon.com.
Biocannabix Health Corporation (BCX), based in
Montreal, Quebec, is a biopharma nutraceutical company focused on
delivering pediatric endo-medicinal nutraceuticals for cannabinoid
therapy.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in policies
of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.
Cautionary Note Regarding
Forward-Looking Statements
This release includes certain statements and
information that may constitute forward-looking information within
the meaning of applicable Canadian and United States securities
laws. All statements in this news release, other than statements of
historical facts, including statements regarding future estimates,
plans, objectives, assumptions or expectations of future
performance, are forward-looking statements and contain
forward-looking information. Generally, forward- looking statements
and information can be identified by the use of forward-looking
terminology such as "intends" or "anticipates", or variations of
such words and phrases or statements that certain actions, events
or results "may", "could", "should", or "would" occur.
Forward-looking statements are based on certain material
assumptions and analysis made by the Company and the opinions and
estimates of management as of the date of this press release. These
forward-looking statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements or forward-looking information.
Although management of the Company has attempted
to identify important factors that could cause actual results to
differ materially from those contained in forward-looking
statements or forward-looking information, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward- looking
statements and forward-looking information. Readers are cautioned
that reliance on such information may not be appropriate for other
purposes. The Company does not undertake to update any
forward-looking statement, forward-looking information or financial
outlook that are incorporated by reference herein, except in
accordance with applicable securities laws. We seek to rely on the
applicable safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES
INC.
Aurelio UsechePresident and CEO
For more information about this press
release:
Tel: +1.888.528.8687
RELEVIUM TECHNOLOGIES
INC
Email: investors@releviumcorp.com Website:
www.releviumtechnologies.com Like us on FacebookFollow us on
Twitter Follow us on LinkedIn
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jul 2024 to Aug 2024
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Aug 2023 to Aug 2024